FDA Rejects Dapagliflozin for Type 2 Diabetes – MedPage Today

Posted by on Jan 19th, 2012 and filed under Alerts & Updates. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

FDA Rejects Dapagliflozin for Type 2 Diabetes – MedPage Today



Updated News
FDA Rejects Dapagliflozin for Type 2 Diabetes
MedPage Today
By Emily P. Walker, Washington Correspondent, MedPage Today WASHINGTON — The FDA said it would not approve the novel diabetes drug dapagliflozin until drugmakers Bristol-Myers Squibb and AstraZeneca supply more data on the drug's benefits and risks.
FDA rejects dapagliflozin for diabetes, raising concerns for a classFierceBiotech
FDA Asks BMS, AstraZeneca for More Clinical Data for AntidiabeticGenetic Engineering News
US rebuffs AstraZeneca, Bristol on diabetes drugReuters
Xconomy -Wall Street Journal (blog) -BusinessWeek
all 53 news articles »

FDA Rejects Dapagliflozin for Type 2 Diabetes – MedPage Today Updated News FDA Rejects Dapagliflozin for Type 2 DiabetesMedPage TodayBy Emily P. Walker, Washington Correspondent, MedPage Today WASHINGTON — The FDA said it would not approve the novel diabetes drug dapagliflozin until drugmakers Bristol-Myers Squibb and AstraZeneca supply more data on the drug's benefits and [...]

You must be logged in to post a comment Login

  • Copyright 2011, www.emedicalnews.net